e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Monitoring and phenotyping COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A liquid chromatography MS/MS metabolomics study of COPD patients
Barbora Novotná (Hradec Kralove, Czech Republic), Barbora Novotna, Mohammed Abdel-Hamid, Vladimir Koblizek, Jiri Jarkovsky, Karel Hejduk, Vit Rehacek, Josef Bis, Frantisek Salajka
Source:
International Congress 2015 – Monitoring and phenotyping COPD
Session:
Monitoring and phenotyping COPD
Session type:
Poster Discussion
Number:
3356
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Barbora Novotná (Hradec Kralove, Czech Republic), Barbora Novotna, Mohammed Abdel-Hamid, Vladimir Koblizek, Jiri Jarkovsky, Karel Hejduk, Vit Rehacek, Josef Bis, Frantisek Salajka. A liquid chromatography MS/MS metabolomics study of COPD patients. Eur Respir J 2015; 46: Suppl. 59, 3356
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Mass spectrometry proteomic biomarkers identify acute COPD exacerbations
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Breath analysis by ion mobility spectrometry in COPD and lung cancer patients
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009
Metabolic profiling detects biomarkers of protein degradation in COPD patients
Source: Eur Respir J 2012; 40: 345-355
Year: 2012
Serum metabolomic analysis of mustard airway diseases by nuclear magnetic resonance spectrometry: A pilot study
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients.
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018
Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014
Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008
Economic impact of point-of-care blood gas analysis in COPD patients
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Ion mobility spectrometry in lung transplant patients
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010
Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Ion mobility spectrometry – a new method in the diagnostic approach to sarcoidosis? Preliminary data
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006
Metabolomic fingerprinting in the identification of biomarkers in COPD patients
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012
Potential markers of the progression of CRF in patients with COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry
Source: Annual Congress 2011 - Clinical application of exhaled biomarkers
Year: 2011
Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
SELDI-TOF biomarkers signatures for cystic fibrosis, asthma and COPD
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept